Display options
Cite
Caraco Y, Linton DM, Muszkat M, et al. Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy. 1998;18(6):1352-5
Caraco, Y., Linton, D. M., Muszkat, M., Shapira, M. Y., & Sviri, S. (1998). Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy, 18(6), 1352-5.
Caraco, Y, et al. "Ticlopidine-induced thrombotic thrombocytopenic purpura." Pharmacotherapy vol. 18,6 (1998): 1352-5.
Caraco Y, Linton DM, Muszkat M, Shapira MY, Sviri S. Ticlopidine-induced thrombotic thrombocytopenic purpura. Pharmacotherapy. 1998 Nov-Dec;18(6):1352-5. PMID: 9855338.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley

Pharmacotherapy. 1998 Nov-Dec;18(6):1352-5.

Ticlopidine-induced thrombotic thrombocytopenic purpura.

Pharmacotherapy

Y Caraco, D M Linton, M Muszkat, M Y Shapira, S Sviri

Affiliations

  1. Division of Medicine, Hadassah University Hospital, Jerusalem, Israel.

PMID: 9855338

Abstract

Thrombotic thrombocytopenic purpura (TTP) occurs in association with a wide variety of disorders including infections, connective tissue diseases, and solid organ tumors. It also may coincide with administration of drugs such as mitomycin, metronidazole, oral contraceptives, cyclosporine, and many others. We report the occurrence of TTP in a patient shortly after the initiation of ticlopidine.

Substances

MeSH terms

Publication Types

LinkOut - more resources